✦ LIBER ✦

MP-08.16: Docetaxel and oral estramustine phosphate in patients with hormone refractory prostate cancer

✍ Scribed by T. Segawa; N. Masuda; Y. Shiraishi; H. Negoro; H. Oka; H. Iwamura; S. Moroi; K. Okubo; T. Okada; M. Kawakita

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-08.09: Docetaxel, etoposide, and estr

✍ K. Nagao; T. Misumi; M. Sasaki; Y. Kawai; S. Eguchi; T. Hara; C. Ohmi; S. Sakano 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Monthly paclitaxel and carboplatin with

✍ Takehiko Segawa; Toshiyuki Kamoto; Hidefumi Kinoshita; Yasuharu Kunishima; Koji 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 378 KB

Phase-II Study of Docetaxel, Estramustin

✍ Nobuyuki Kikuno; Shinji Urakami; Shigeru Nakamura; Takeo Hiraoka; Taijyu Hyuga; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Safety and efficacy of docetaxel, estram

✍ Yoshihiro Nakagami; Makoto Ohori; Noboru Sakamoto; Shoji Koga; Riu Hamada; Tadas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Intermittent docetaxel therapy with estr

✍ Norihito Soga; Manabu Kato; Kouhei Nishikawa; Yoshihiro Hasegawa; Yasushi Yamada 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Docetaxel in combination with estramusti

✍ António Canelas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 182 KB